Stock Events

iRhythm Technologies 

$69.78
20
-$0.2-0.28% Today

Statistics

Day High
70.47
Day Low
69.47
52W High
124.12
52W Low
60.88
Volume
47,666
Avg. Volume
479,196
Mkt Cap
2.21B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
-1.47
-1.12
-0.78
-0.43
Expected EPS
-0.570788
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IRTC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap197.08B
Abbott Laboratories offers a broad range of medical devices, including cardiac monitors that compete with iRhythm's Zio patch.
Medtronic
MDT
Mkt Cap113.61B
Medtronic provides a variety of cardiac monitoring solutions, directly competing with iRhythm's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Bio-Rad Laboratories, Inc. offers products and services in the field of clinical diagnostics and life science research, which includes technologies that can compete in the cardiac monitoring space.
Koninklijke Philips N.V.
PHG
Mkt Cap28.48B
Philips is a diversified health and well-being company, with a strong presence in the healthcare sector, including cardiac monitoring technologies.
Hologic
HOLX
Mkt Cap18.87B
Hologic, Inc. specializes in medical devices and diagnostics, with products that could compete in the broader market for cardiac health monitoring.
Masimo
MASI
Mkt Cap6.25B
Masimo Corporation offers medical technologies that are competitive in the patient monitoring space, including pulse oximetry and heart rate monitoring.
Dexcom
DXCM
Mkt Cap27.79B
DexCom, Inc. specializes in glucose monitoring systems but its expansion into broader health monitoring technologies positions it as a potential competitor.
Boston Scientific
BSX
Mkt Cap120.45B
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in a range of interventional medical specialties, including cardiac monitoring.
Stryker
SYK
Mkt Cap137.35B
Stryker Corporation, a medical technologies firm, has a broad portfolio that could compete with iRhythm Technologies in the development of future cardiac or health monitoring solutions.

Analyst Ratings

118.67$Average Price Target
The highest estimate is $145.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Show more...
CEO
Kevin King
Employees
2000
Country
US
ISIN
US4500561067

Listings